
Cerner Corporation CERN
Quartalsbericht 2022-Q1
hinzugefügt 16.05.2026
Cerner Corporation Finanzkreislauf 2011-2026 | CERN
Finanzkreislauf Jährlich Cerner Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -20 | -14.1 | -13.9 | -16.1 | -20.6 | -17.6 | -5.13 | - | -8.86 | 24.2 | 64.8 | -16.6 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 64.8 | -20.6 | -4 |
Finanzkreislauf Vierteljährlich Cerner Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | -43.8 | - | -32.4 | -22.5 | -14.2 | 76.5 | -11.7 | -30.8 | -19.1 | 72.1 | -11.3 | -12.3 | -17.2 | 79.1 | -25.8 | -23.6 | -14.5 | 72.4 | -16.8 | -9.5 | -25.9 | 68.5 | -38.6 | -28.3 | -28.7 | 85 | -4.03 | -5.05 | -3.76 | - | -17.1 | 2.84 | -7.6 | 66.9 | -12.9 | -6.58 | -4.69 | 74.2 | 6.25 | 10 | 29.3 | 83.5 | 42.8 | 40.4 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 85 | -43.8 | 7.64 |
Finanzkreislauf anderer Aktien in der Gesundheitsdienste
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Evolent Health
EVH
|
266 | $ 3.97 | 0.38 % | $ 453 M | ||
|
Accolade
ACCD
|
-4.64 | - | 0.29 % | $ 206 M | ||
|
Change Healthcare
CHNG
|
76.2 | - | - | $ 9.03 B | ||
|
Computer Programs and Systems
CPSI
|
19.6 | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
52.1 | - | - | $ 2.94 B | ||
|
Castlight Health, Inc.
CSLT
|
68.7 | - | -7.28 % | $ 227 M | ||
|
HMS Holdings Corp.
HMSY
|
-587 | - | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
56.1 | - | - | $ 6.37 B | ||
|
HealthEquity
HQY
|
21.5 | $ 87.65 | -0.52 % | $ 7.55 B | ||
|
iCAD
ICAD
|
117 | - | - | $ 102 M | ||
|
GoodRx Holdings
GDRX
|
-18.9 | $ 2.79 | 5.28 % | $ 994 M | ||
|
Akerna Corp.
KERN
|
-3.52 | - | - | $ 161 M | ||
|
10x Genomics
TXG
|
143 | $ 24.88 | 5.07 % | $ 3.1 B | ||
|
Allscripts Healthcare Solutions
MDRX
|
192 | - | -10.39 % | $ 886 M | ||
|
MTBC
MTBC
|
42.2 | - | -0.58 % | $ 51.7 M | ||
|
1Life Healthcare
ONEM
|
33.8 | - | - | $ 3.37 B | ||
|
NextGen Healthcare
NXGN
|
37.1 | - | - | $ 1.6 B | ||
|
Premier
PINC
|
110 | - | - | $ 2.33 B | ||
|
Health Catalyst
HCAT
|
44.4 | $ 1.26 | -2.19 % | $ 88.1 M | ||
|
OptimizeRx Corporation
OPRX
|
107 | $ 4.87 | -1.42 % | $ 90.4 M | ||
|
Schrödinger
SDGR
|
192 | $ 13.35 | 0.38 % | $ 980 M | ||
|
Phreesia
PHR
|
21.2 | $ 8.93 | 0.11 % | $ 533 M | ||
|
R1 RCM
RCM
|
21.9 | - | - | $ 3.81 B | ||
|
Teladoc Health
TDOC
|
28.2 | $ 6.7 | 1.9 % | $ 1.18 B | ||
|
Signify Health
SGFY
|
214 | - | -0.02 % | $ 7.21 B | ||
|
Streamline Health Solutions
STRM
|
59.4 | - | - | $ 21.4 M | ||
|
NantHealth
NH
|
-54.1 | - | -46.64 % | $ 10.4 M | ||
|
SCWorx Corp.
WORX
|
43.5 | - | - | $ 7.71 M | ||
|
American Well Corporation
AMWL
|
84.9 | $ 8.21 | 3.08 % | $ 132 M | ||
|
Tabula Rasa HealthCare
TRHC
|
12 | - | - | $ 255 M | ||
|
HealthStream
HSTM
|
12.9 | $ 23.64 | -0.71 % | $ 710 M | ||
|
Omnicell
OMCL
|
98 | $ 44.62 | 0.47 % | $ 2.05 B | ||
|
Progyny
PGNY
|
95.5 | $ 25.1 | 0.88 % | $ 2.14 B | ||
|
So-Young International
SY
|
95.5 | $ 2.35 | 5.16 % | $ 183 M | ||
|
Veeva Systems
VEEV
|
114 | $ 159.42 | -0.47 % | $ 26.1 B | ||
|
Zhongchao
ZCMD
|
-31 | $ 1.43 | - | $ 4.89 M |